Tristel Share News (TSTL)
TSTL Share
TSTL Share
TSTL Share
TSTL Share
TSTL
TSTL Share
TSTL Level 2
TSTL Live
TSTL Broker
TSTL Directors
TSTL Financial
TSTL
TSTL Short
TSTL
Last checked at -
Lancashire Holdings non-executive director Barry Volpert is chief executive of private equity firm Crestview, which has raised more than £4.7m from the sale of shares in the property, aviation and marine insurer. The share prices of the five separate disposals varied from 497p to just over 500p. C
Read moreDisinfectant supplier Tristel posted a rise in turnover and profits in the six months to December 31 as it proceeded with the integration of a portfolio of products it acquired from Medichem. Pre-tax profits climbed to £656,000 from £469,000 over the same period the previous year as revenues climbe
Read moreUltra Electronics chief executive Douglas Caster has generated £5.85m from the sale of just over two-fifths of his shareholding in the defence electronics supplier. He states in the announcement that the sale was for "family and tax planning reasons". Caster has also transferred his remaining 63
Read moreOil group Nautical Petroleum reported 'significant progress' in its asset portfolio in the year to June 30 and said it expects its assets to rise in value once they move into the execution stage. Pre-tax losses for the year totalled £6.63m, compared with £4.52m the previous year. Shares in e-learn
Read moreTristel chief executive Paul Swinney described the infection and contamination control company's results as 'good, if not spectacular' but his modesty contrasts with his excitement about the prospect of overseas expansion. In the year to June 30, Tristel, whose products are used to combat infection
Read moreThe continuing struggle to keep infections such as Clostridium difficile out of hospitals helped disinfectant supplier Tristel post a rise in turnover and profits in the year to June 30. Tristel, whose products are based on chlorine dioxide chemistry, said revenues climbed to £6.8m from £6m over th
Read moreFrancisco Soler, non-executive chairman of Tristel, sold £315,680 worth of shares in the disinfectant supplier to satisfy institutional demand following the group's oversubscribed placing. Soler disposed of 769,951 shares in Tristel at 41p each as the group raised £1m to part finance the purchase
Read moreDisinfectant supplier Tristel has raised £1m to part finance the purchase of a portfolio of infection control products for between £2.15m and £2.4m. It has placed 2.7m shares at 41p each, which will help buy intellectual property and manufacturing rights from Medichem International. The placing was
Read more
Last checked at